Atrium Therapeutics shares rise on $50M private placement
Atrium Therapeutics entered a securities-purchase agreement for a private placement, with shares up 12% to $8.90 in premarket trading.
90, in premarket trading Thursday. Through Wednesday's close, shares have lost nearly…